CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 40 filers reported holding CYTEIR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020,980 | +9.2% | 359,500 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $934,700 | +42.9% | 359,500 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $654,290 | +10.3% | 359,500 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $593,175 | -14.0% | 359,500 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $690,000 | -35.8% | 359,500 | 0.0% | 0.00% | -76.5% |
| Q2 2022 | $1,075,000 | – | 359,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $4,476,421 | 8.93% |
| Novo Holdings A/S | 3,940,413 | $112,892,832 | 7.45% |
| BML Capital Management, LLC | 3,146,296 | $5,726,259 | 4.95% |
| Newtyn Management, LLC | 952,947 | $1,734,364 | 0.34% |
| Aldebaran Capital, LLC | 151,239 | $275,255 | 0.28% |
| Avidity Partners Management LP | 1,764,100 | $3,210,662 | 0.11% |
| Marquette Asset Management, LLC | 67,990 | $123,742 | 0.03% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $182,000 | 0.03% |
| RBF Capital, LLC | 117,295 | $213,477 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 150,406 | $273,739 | 0.02% |